These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8732470)

  • 21. The metabolic consequences of treating postmenopausal women with non-oral hormone replacement therapy.
    Crook D
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():4-13. PubMed ID: 9389777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT.
    L'Hermite M
    Climacteric; 2013 Aug; 16 Suppl 1():44-53. PubMed ID: 23848491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy and the breast.
    Dixon JM
    Surg Oncol; 2003 Dec; 12(4):251-63. PubMed ID: 14998565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
    J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal replacement therapy (HRT) in postmenopause: a reappraisal.
    Caufriez A
    Ann Endocrinol (Paris); 2007 Sep; 68(4):241-50. PubMed ID: 17651686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of antiandrogens in hormone replacement therapy.
    Schneider HP
    Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy: who should be treated?
    Gambacciani M; Levancini M
    Minerva Ginecol; 2015 Jun; 67(3):249-55. PubMed ID: 25677950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal estrogens in the changing landscape of hormone replacement therapy.
    Beck KL; Anderson MC; Kirk JK
    Postgrad Med; 2017 Aug; 129(6):632-636. PubMed ID: 28540770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy. Clinical synthesis panel on HRT.
    J Epidemiol Biostat; 1999; 4(3):123-8. PubMed ID: 10695954
    [No Abstract]   [Full Text] [Related]  

  • 33. HRT management: the American experience.
    Carr BR
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S17-20. PubMed ID: 8732468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The practicalities of hormone replacement therapy.
    Marsh MS; Whitehead MI
    Baillieres Clin Endocrinol Metab; 1993 Jan; 7(1):183-202. PubMed ID: 8435052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society.
    Gambacciani M; Biglia N; Cagnacci A; Caruso S; Cicinelli E; DE Leo V; DI Carlo C; Farris M; Gambera A; Guaschino S; Lanzone A; Paoletti AM; Russo N; Vicariotto F; Villa P; Volpe A;
    Minerva Ginecol; 2018 Feb; 70(1):27-34. PubMed ID: 28975776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits of hormone replacement therapy--overview and update.
    Calaf i Alsina J
    Int J Fertil Womens Med; 1997; 42 Suppl 2():329-46. PubMed ID: 9397382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women.
    Panay N; Studd J
    Hum Reprod Update; 1997; 3(2):159-71. PubMed ID: 9286739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy in the aged. A state of the art review.
    Jacobs S; Hillard TC
    Drugs Aging; 1996 Mar; 8(3):193-213. PubMed ID: 8720745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.